Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Han, 2005, Factors that impact developability of drug candidates: an overview, 1
Saltzman, 2001
Torchilin, 2010, Passive and active drug targeting: drug delivery to tumors as an example, 3
Jain, 2008, Drug delivery systems — an overview, 1
Karunaratne, 2005, Cell culture models for drug transport studies, 103
Haycock, 2011, 3D cell culture: a review of current approaches and techniques, Methods Mol. Biol., 695, 1, 10.1007/978-1-60761-984-0_1
Ingram, 1997, Three-dimensional growth patterns of various human tumor cell lines in simulated microgravity of a NASA bioreactor, In Vitro Cell. Dev. Biol. Anim., 33, 459, 10.1007/s11626-997-0064-8
Torisawa, 2005, A multicellular spheroid-based drug sensitivity test by scanning electrochemical microscopy, Oncol. Rep., 13, 1107
Kelm, 2004, Microscale tissue engineering using gravity-enforced cell assembly, Trends Biotechnol., 22, 195, 10.1016/j.tibtech.2004.02.002
Olive, 1992, Detection of hypoxic cells in a murine tumor with the use of the comet assay, J. Natl. Cancer Inst., 84, 707, 10.1093/jnci/84.9.707
Oloumi, 2002, Identification of genes differentially expressed in V79 cells grown as multicell spheroids, Int. J. Radiat. Biol., 78, 483, 10.1080/09553000210122299
Kim, 2011, The reciprocal interaction: chemotherapy and tumor microenvironment, Curr. Drug Discov. Technol., 8, 102, 10.2174/157016311795563875
Shekhar, 2011, Drug resistance: challenges to effective therapy, Curr. Cancer Drug Targets, 11, 613, 10.2174/156800911795655921
Andre, 2010, Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients, Curr. Opin. Oncol., 22, 547, 10.1097/CCO.0b013e32833fb384
Lin, 2008, Recent advances in three-dimensional multicellular spheroid culture for biomedical research, Biotechnol. J., 3, 1172, 10.1002/biot.200700228
Kunz-Schughart, 2004, The use of 3-D cultures for high-throughput screening: the multicellular spheroid model, J. Biomol. Screen., 9, 273, 10.1177/1087057104265040
Hirschhaeuser, 2010, Multicellular tumor spheroids: an underestimated tool is catching up again, J. Biotechnol., 148, 3, 10.1016/j.jbiotec.2010.01.012
Bredel-Geissler, 1992, Proliferation-associated oxygen consumption and morphology of tumor cells in monolayer and spheroid culture, J. Cell. Physiol., 153, 44, 10.1002/jcp.1041530108
Gassmann, 1996, Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells, Proc. Natl. Acad. Sci. U. S. A., 93, 2867, 10.1073/pnas.93.7.2867
Kunz-Schughart, 1996, Three-dimensional cell culture induces novel proliferative and metabolic alterations associated with oncogenic transformation, Int. J. Cancer, 66, 578, 10.1002/(SICI)1097-0215(19960516)66:4<578::AID-IJC25>3.0.CO;2-2
Sutherland, 1988, Cell and environment interactions in tumor microregions: the multicell spheroid model, Science, 240, 177, 10.1126/science.2451290
Wartenberg, 2001, Tumor-induced angiogenesis studied in confrontation cultures of multicellular tumor spheroids and embryoid bodies grown from pluripotent embryonic stem cells, FASEB J., 15, 995, 10.1096/fj.00-0350com
Krohn, 2009, CXCR4 receptor positive spheroid forming cells are responsible for tumor invasion in vitro, Cancer Lett., 280, 65, 10.1016/j.canlet.2009.02.005
Bartosh, 2010, Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties, Proc. Natl. Acad. Sci. U. S. A., 107, 13724, 10.1073/pnas.1008117107
Fang, 2010, Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery, Br. J. Cancer, 102, 1265, 10.1038/sj.bjc.6605610
Bratt-Leal, 2011, Magnetic manipulation and spatial patterning of multi-cellular stem cell aggregates, Integr. Biol. (Camb.), 3, 1224, 10.1039/c1ib00064k
Huang, 2011, Spheroid formation of mesenchymal stem cells on chitosan and chitosan–hyaluronan membranes, Biomaterials, 32, 6929, 10.1016/j.biomaterials.2011.05.092
Miyagawa, 2011, A microfabricated scaffold induces the spheroid formation of human bone marrow-derived mesenchymal progenitor cells and promotes efficient adipogenic differentiation, Tissue Eng. Part A, 17, 513, 10.1089/ten.tea.2009.0810
Raof, 2011, Bioengineering embryonic stem cell microenvironments for exploring inhibitory effects on metastatic breast cancer cells, Biomaterials, 32, 4130, 10.1016/j.biomaterials.2011.02.035
Cheng, 2012, The influence of spheroid formation of human adipose-derived stem cells on chitosan films on stemness and differentiation capabilities, Biomaterials, 33, 1748, 10.1016/j.biomaterials.2011.11.049
Hsu, 2012, Nanoparticle uptake and gene transfer efficiency for MSCs on chitosan and chitosan–hyaluronan substrates, Biomaterials, 33, 3639, 10.1016/j.biomaterials.2012.02.005
Hsueh, 2012, Spheroid formation and neural induction in human adipose-derived stem cells on a chitosan-coated surface, Cells Tissues Organs, 10.1159/000332045
Lopez, 2012, Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance, BMC Cancer, 12, 48, 10.1186/1471-2407-12-48
Montales, 2012, Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cells, Carcinogenesis, 33, 652, 10.1093/carcin/bgr317
Wang, 2012, Isolation and characterization of stem-like cells from a human ovarian cancer cell line, Mol. Cell. Biochem., 363, 257, 10.1007/s11010-011-1178-6
Zhang, 2012, Three-dimensional spheroid culture of human gingiva-derived mesenchymal stem cells enhances mitigation of chemotherapy-induced oral mucositis, Stem Cells Dev., 21, 937, 10.1089/scd.2011.0252
Venkatasubramanian, 2006, Incorporating energy metabolism into a growth model of multicellular tumor spheroids, J. Theor. Biol., 242, 440, 10.1016/j.jtbi.2006.03.011
Ward, 2003, Mathematical modelling of drug transport in tumour multicell spheroids and monolayer cultures, Math. Biosci., 181, 177, 10.1016/S0025-5564(02)00148-7
Wenning, 1999, Coupled cellular trafficking and diffusional limitations in delivery of immunotoxins to multicell tumor spheroids, Biotechnol. Bioeng., 62, 562, 10.1002/(SICI)1097-0290(19990305)62:5<562::AID-BIT8>3.0.CO;2-4
Owen, 2004, Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites, J. Theor. Biol., 226, 377, 10.1016/j.jtbi.2003.09.004
Webb, 2007, Macrophage-based anti-cancer therapy: modelling different modes of tumour targeting, Bull. Math. Biol., 69, 1747, 10.1007/s11538-006-9189-2
Goodman, 2008, Spatio-temporal modeling of nanoparticle delivery to multicellular tumor spheroids, Biotechnol. Bioeng., 101, 388, 10.1002/bit.21910
Friedrich, 2007, Experimental anti-tumor therapy in 3-D: spheroids—old hat or new challenge?, Int. J. Radiat. Biol., 83, 849, 10.1080/09553000701727531
Torisawa, 2007, A multicellular spheroid array to realize spheroid formation, culture, and viability assay on a chip, Biomaterials, 28, 559, 10.1016/j.biomaterials.2006.08.054
Ungrin, 2008, Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates, PLoS One, 3, e1565, 10.1371/journal.pone.0001565
Kelm, 2003, Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types, Biotechnol. Bioeng., 83, 173, 10.1002/bit.10655
Kelm, 2006, Design of custom-shaped vascularized tissues using microtissue spheroids as minimal building units, Tissue Eng., 12, 2151, 10.1089/ten.2006.12.2151
Kelm, 2010, Scaffold-free cell delivery for use in regenerative medicine, Adv. Drug Deliv. Rev., 62, 753, 10.1016/j.addr.2010.02.003
Ong, 2008, A gel-free 3D microfluidic cell culture system, Biomaterials, 29, 3237, 10.1016/j.biomaterials.2008.04.022
Torisawa, 2007, Efficient formation of uniform-sized embryoid bodies using a compartmentalized microchannel device, Lab. Chip, 7, 770, 10.1039/b618439a
Wu, 2008, Microfluidic self-assembly of tumor spheroids for anticancer drug discovery, Biomed. Microdevices, 10, 197, 10.1007/s10544-007-9125-8
Fukuda, 2006, Micromolding of photocrosslinkable chitosan hydrogel for spheroid microarray and co-cultures, Biomaterials, 27, 5259, 10.1016/j.biomaterials.2006.05.044
Sodunke, 2007, Micropatterns of matrigel for three-dimensional epithelial cultures, Biomaterials, 28, 4006, 10.1016/j.biomaterials.2007.05.021
Gotoh, 2011, Spheroid formation and expression of liver-specific functions of human hepatocellular carcinoma-derived FLC-4 cells cultured in lactose-silk fibroin conjugate sponges, Biomacromolecules, 12, 1532, 10.1021/bm101495c
Torisawa, 2009, Microfluidic hydrodynamic cellular patterning for systematic formation of co-culture spheroids, Integr. Biol. (Camb.), 1, 649, 10.1039/b915965g
Lee, 2011, Diffusion-mediated in situ alginate encapsulation of cell spheroids using microscale concave well and nanoporous membrane, Lab. Chip, 11, 1168, 10.1039/c0lc00540a
Yoshii, 2011, The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation, Biomaterials, 32, 6052, 10.1016/j.biomaterials.2011.04.076
Cordey, 2008, Enhancing the reliability and throughput of neurosphere culture on hydrogel microwell arrays, Stem Cells, 26, 2586, 10.1634/stemcells.2008-0498
Tung, 2011, High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array, Analyst, 136, 473, 10.1039/C0AN00609B
Hsiao, 2011, 384 hanging drop arrays give excellent Z-factors and allow versatile formation of co-culture spheroids, Biotechnol. Bioeng., 109, 1293, 10.1002/bit.24399
Hsiao, 2011, Micro-ring structures stabilize microdroplets to enable long term spheroid culture in 384 hanging drop array plates, Biomed. Microdevices, 14, 313, 10.1007/s10544-011-9608-5
Cioce, 2010, Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs, Cell Cycle, 9, 2878, 10.4161/cc.9.14.12371
Ginestier, 2009, Retinoid signaling regulates breast cancer stem cell differentiation, Cell Cycle, 8, 3297, 10.4161/cc.8.20.9761
Chen, 2011, Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells, Clin. Exp. Metastasis, 28, 751, 10.1007/s10585-011-9407-7
Oh, 2011, Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells, Am. J. Physiol. Gastrointest. Liver Physiol., 301, G347, 10.1152/ajpgi.00403.2010
Wan, 2010, The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research, Brain Pathol., 20, 877, 10.1111/j.1750-3639.2010.00379.x
Deleyrolle, 2011, Determination of somatic and cancer stem cell self-renewing symmetric division rate using sphere assays, PLoS One, 6, e15844, 10.1371/journal.pone.0015844
Anaka, 2012, Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profile, Stem Cells, 30, 336, 10.1002/stem.786
Meng, 2006, Direct self-assembly of hepatocytes spheroids within hollow fibers in presence of collagen, Biotechnol. Lett., 28, 279, 10.1007/s10529-005-5531-2
Haeger, 2011, Formation of bovine placental trophoblast spheroids, Cells Tissues Organs, 193, 274, 10.1159/000320544
Ivascu, 2006, Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis, J. Biomol. Screen., 11, 922, 10.1177/1087057106292763
Korff, 2004, Three-dimensional spheroidal culture of cytotrophoblast cells mimics the phenotype and differentiation of cytotrophoblasts from normal and preeclamptic pregnancies, Exp. Cell Res., 297, 415, 10.1016/j.yexcr.2004.03.043
Korff, 1998, Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation, J. Cell Biol., 143, 1341, 10.1083/jcb.143.5.1341
Xin, 2007, Self-renewal and multilineage differentiation in vitro from murine prostate stem cells, Stem Cells, 25, 2760, 10.1634/stemcells.2007-0355
Griffith, 2006, Capturing complex 3D tissue physiology in vitro, Nat. Rev. Mol. Cell Biol., 7, 211, 10.1038/nrm1858
Steeg, 2006, Tumor metastasis: mechanistic insights and clinical challenges, Nat. Med., 12, 895, 10.1038/nm1469
Gilbert, 2010, DNA damage-mediated induction of a chemoresistant niche, Cell, 143, 355, 10.1016/j.cell.2010.09.043
Upreti, 2011, Tumor-endothelial cell three-dimensional spheroids: new aspects to enhance radiation and drug therapeutics, Transl. Oncol., 4, 365, 10.1593/tlo.11187
Otsuka, 2004, Two-dimensional multiarray formation of hepatocyte spheroids on a microfabricated PEG-brush surface, ChemBioChem, 5, 850, 10.1002/cbic.200300822
Leclerc, 2004, Microfluidic PDMS (polydimethylsiloxane) bioreactor for large-scale culture of hepatocytes, Biotechnol. Prog., 20, 750, 10.1021/bp0300568
Chen, 2010, Alginate-based microfluidic system for tumor spheroid formation and anticancer agent screening, Biomed. Microdevices, 12, 647, 10.1007/s10544-010-9417-2
Friedl, 2011, Cancer invasion and the microenvironment: plasticity and reciprocity, Cell, 147, 992, 10.1016/j.cell.2011.11.016
Kaur, 2011, Human breast cancer histoid: an in vitro 3-dimensional co-culture model that mimics breast cancer tissue, J. Histochem. Cytochem., 59, 1087, 10.1369/0022155411423680
Ingram, 2010, Tissue engineered tumor models, Biotech. Histochem., 85, 213, 10.3109/10520295.2010.483655
Toh, 2007, A novel 3D mammalian cell perfusion-culture system in microfluidic channels, Lab. Chip, 7, 302, 10.1039/b614872g
Karp, 2007, Controlling size, shape and homogeneity of embryoid bodies using poly(ethylene glycol) microwells, Lab. Chip, 7, 786, 10.1039/b705085m
Chua, 2005, Stable immobilization of rat hepatocyte spheroids on galactosylated nanofiber scaffold, Biomaterials, 26, 2537, 10.1016/j.biomaterials.2004.07.040
Elkayam, 2006, Enhancing the drug metabolism activities of C3A–a human hepatocyte cell line–by tissue engineering within alginate scaffolds, Tissue Eng., 12, 1357, 10.1089/ten.2006.12.1357
Glicklis, 2000, Hepatocyte behavior within three-dimensional porous alginate scaffolds, Biotechnol. Bioeng., 67, 344, 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2
Kotov, 2004, Inverted colloidal crystals as three-dimensional cell scaffolds, Langmuir, 20, 7887, 10.1021/la049958o
Lee, 2006, Inverted colloidal crystals as three-dimensional microenvironments for cellular co-cultures, J. Mater. Chem., 16, 3558, 10.1039/b605797g
Torok, 2006, Morphological and functional analysis of rat hepatocyte spheroids generated on poly(L-lactic acid) polymer in a pulsatile flow bioreactor, Tissue Eng., 12, 1881, 10.1089/ten.2006.12.1881
Drewitz, 2011, Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues, Biotechnol. J., 6, 1488, 10.1002/biot.201100290
Bryce, 2009, Accumulation of an anthraquinone and its platinum complexes in cancer cell spheroids: the effect of charge on drug distribution in solid tumour models, Chem. Commun. (Camb.), 2673, 10.1039/b902415h
Kostarelos, 2005, Engineering lipid vesicles of enhanced intratumoral transport capabilities: correlating liposome characteristics with penetration into human prostate tumor spheroids, J. Liposome Res., 15, 15, 10.1081/LPR-64953
Oishi, 2007, Enhanced growth inhibition of hepatic multicellular tumor spheroids by lactosylated poly(ethylene glycol)-siRNA conjugate formulated in PEGylated polyplexes, ChemMedChem, 2, 1290, 10.1002/cmdc.200700076
Ying, 2010, Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals, J. Control. Release, 141, 183, 10.1016/j.jconrel.2009.09.020
Durand, 1992, Evaluation of bioreductive drugs in multicell spheroids, Int. J. Radiat. Oncol. Biol. Phys., 22, 689, 10.1016/0360-3016(92)90504-B
He, 2010, Automated microfluidic protein immunoblotting, Nat. Protoc., 5, 1844, 10.1038/nprot.2010.142
Paguirigan, 2010, Expanding the available assays: adapting and validating in-cell westerns in microfluidic devices for cell-based assays, Assay Drug Dev. Technol., 8, 591, 10.1089/adt.2010.0274
Wlodkowic, 2011, Rise of the micromachines: microfluidics and the future of cytometry, Methods Cell Biol., 102, 105, 10.1016/B978-0-12-374912-3.00005-5
Birmingham, 2009, Statistical methods for analysis of high-throughput RNA interference screens, Nat. Methods, 6, 569, 10.1038/nmeth.1351
Sui, 2007, Alternative statistical parameter for high-throughput screening assay quality assessment, J. Biomol. Screen., 12, 229, 10.1177/1087057106296498
Zhang, 1999, A simple statistical parameter for use in evaluation and validation of high throughput screening assays, J. Biomol. Screen., 4, 67, 10.1177/108705719900400206
Scott, 2011, Bioluminescence and its impact on bioanalysis, Ann. Rev. Anal. Chem., 4, 297, 10.1146/annurev-anchem-061010-113855
McMillin, 2010, Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity, Nat. Med., 16, 483, 10.1038/nm.2112
Michelini, 2010, Cell-based assays: fuelling drug discovery, Anal. Bioanal. Chem., 398, 227, 10.1007/s00216-010-3933-z
Sweeney, 1999, Visualizing the kinetics of tumor-cell clearance in living animals, Proc. Natl. Acad. Sci. U. S. A., 96, 12044, 10.1073/pnas.96.21.12044
Luker, 2011, Luciferase protein complementation assays for bioluminescence imaging of cells and mice, Methods Mol. Biol., 680, 29, 10.1007/978-1-60761-901-7_2
Luker, 2012, In vivo imaging of ligand receptor binding with Gaussia luciferase complementation, Nat. Med., 18, 172, 10.1038/nm.2590
Molema, 2001, Drug targeting: basic concepts and novel advances, 1
Parthasarathy, 1994, Interaction of liposome-associated all-trans-retinoic acid with squamous carcinoma cells, Cancer Chemother. Pharmacol., 34, 527, 10.1007/BF00685666
Kostarelos, 2004, Binding and interstitial penetration of liposomes within avascular tumor spheroids, Int. J. Cancer, 112, 713, 10.1002/ijc.20457
Emfietzoglou, 2005, Liposome-mediated radiotherapeutics within avascular tumor spheroids: comparative dosimetry study for various radionuclides, liposome systems, and a targeting antibody, J. Nucl. Med., 46, 89
Mellor, 2006, Optimising non-viral gene delivery in a tumour spheroid model, J. Gene Med., 8, 1160, 10.1002/jgm.947
Goodman, 2007, Increased nanoparticle penetration in collagenase-treated multicellular spheroids, Int. J. Nanomedicine, 2, 265
Dhanikula, 2008, Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability, Mol. Pharm., 5, 105, 10.1021/mp700086j
Mairs, 1995, Enhanced tumour uptake and in vitro radiotoxicity of no-carrier-added [131I]meta-iodobenzylguanidine: implications for the targeted radiotherapy of neuroblastoma, Eur. J. Cancer, 31A, 576, 10.1016/0959-8049(95)00052-K
Gaze, 1992, 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes, Br. J. Cancer, 66, 1048, 10.1038/bjc.1992.408
Lenartz, 1998, Efficiency of treatment with galactoside-specific lectin from mistletoe against rat glioma, Anticancer. Res., 18, 1011
Durand, 1990, Slow penetration of anthracyclines into spheroids and tumors: a therapeutic advantage?, Cancer Chemother. Pharmacol., 26, 198, 10.1007/BF02897199
Bell, 1999, Effects of N-6 essential fatty acids on glioma invasion and growth: experimental studies with glioma spheroids in collagen gels, J. Neurosurg., 91, 989, 10.3171/jns.1999.91.6.0989
Desoize, 1998, Cell culture as spheroids: an approach to multicellular resistance, Anticancer. Res., 18, 4147
Olive, 1994, Drug and radiation resistance in spheroids: cell contact and kinetics, Cancer Metastasis Rev., 13, 121, 10.1007/BF00689632
Knuchel, 1989, Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy, Cancer Res., 49, 1397
Kwok, 1985, The response to cytotoxic drugs of EMT6 cells treated either as intact or disaggregated spheroids, Br. J. Cancer, 51, 211, 10.1038/bjc.1985.31
Oloumi, 2000, Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors, Cancer Res., 60, 5747
Wibe, 1980, Resistance to vincristine of human cells grown as multicellular spheroids, Br. J. Cancer, 42, 937, 10.1038/bjc.1980.344
Desoize, 2000, Multicellular resistance: a paradigm for clinical resistance?, Crit. Rev. Oncol. Hematol., 36, 193, 10.1016/S1040-8428(00)00086-X
Durand, 2001, Resistance of tumor cells to chemo- and radiotherapy modulated by the three-dimensional architecture of solid tumors and spheroids, Methods Cell Biol., 64, 211, 10.1016/S0091-679X(01)64015-9
Friedrich, 2009, Spheroid-based drug screen: considerations and practical approach, Nat. Protoc., 4, 309, 10.1038/nprot.2008.226
Kerr, 1988, Cytotoxic drug penetration studies in multicellular tumour spheroids, Xenobiotica, 18, 641, 10.3109/00498258809041702
Kunz-Schughart, 1999, Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor, Cell Biol. Int., 23, 157, 10.1006/cbir.1999.0384
Kwok, 1985, The relationship between tumour geometry and the response of tumour cells to cytotoxic drugs—an in vitro study using EMT6 multicellular spheroids, Int. J. Cancer, 35, 675, 10.1002/ijc.2910350517
Erlanson, 1992, Relations between the penetration, binding and average concentration of cytostatic drugs in human tumour spheroids, Cancer Chemother. Pharmacol., 29, 343, 10.1007/BF00686002
Durand, 1986, Chemosensitivity testing in V79 spheroids: drug delivery and cellular microenvironment, J. Natl. Cancer Inst., 77, 247
Erlichman, 1984, Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice, Cancer Res., 44, 5369
Kozin, 1998, Cytotoxicity of weak electrolytes after the adaptation of cells to low pH: role of the transmembrane pH gradient, Br. J. Cancer, 77, 1580, 10.1038/bjc.1998.260
Tannock, 1989, Acid pH in tumors and its potential for therapeutic exploitation, Cancer Res., 49, 4373
Mueller-Klieser, 2000, Tumor biology and experimental therapeutics, Crit. Rev. Oncol. Hematol., 36, 123, 10.1016/S1040-8428(00)00082-2
Dubessy, 2000, Spheroids in radiobiology and photodynamic therapy, Crit. Rev. Oncol. Hematol., 36, 179, 10.1016/S1040-8428(00)00085-8
Hirschberg, 2004, Enhanced cytotoxic effects of 5-aminolevulinic acid-mediated photodynamic therapy by concurrent hyperthermia in glioma spheroids, J. Neurooncol., 70, 289, 10.1007/s11060-004-9161-7
Kunz-Schughart, 1998, Multicellular spheroids: a three-dimensional in vitro culture system to study tumour biology, Int. J. Exp. Pathol., 79, 1, 10.1046/j.1365-2613.1998.00051.x
Mueller-Klieser, 1987, Multicellular spheroids. A review on cellular aggregates in cancer research, J. Cancer Res. Clin. Oncol., 113, 101, 10.1007/BF00391431
Santini, 1999, Three-dimensional spheroid model in tumor biology, Pathobiology, 67, 148, 10.1159/000028065
Santini, 1999, Multicellular tumour spheroids in radiation biology, Int. J. Radiat. Biol., 75, 787, 10.1080/095530099139845
Sutherland, 1984, Growth and cellular characteristics of multicell spheroids, Recent Results Cancer Res., 95, 24, 10.1007/978-3-642-82340-4_2
Carlsson, 1989, Tumour spheroid technology in cancer therapy research, Eur. J. Cancer Clin. Oncol., 25, 1127, 10.1016/0277-5379(89)90404-5
Mueller-Klieser, 1997, Three-dimensional cell cultures: from molecular mechanisms to clinical applications, Am. J. Physiol., 273, C1109, 10.1152/ajpcell.1997.273.4.C1109
Bates, 2000, Spheroids and cell survival, Crit. Rev. Oncol. Hematol., 36, 61, 10.1016/S1040-8428(00)00077-9
de Ridder, 2000, Autologous spheroid culture: a screening tool for human brain tumour invasion, Crit. Rev. Oncol. Hematol., 36, 107, 10.1016/S1040-8428(00)00081-0
Shield, 2009, Multicellular spheroids in ovarian cancer metastases: biology and pathology, Gynecol. Oncol., 113, 143, 10.1016/j.ygyno.2008.11.032